Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential

Cancer Immunology, Immunotherapy

Volumn 58, Issue 8, 2009, Pages 1307-1317

  Terai, Mizue ^a,b   Tamura, Yutaka ^b   Alexeev, Vitali ^a   Ohtsuka, Eiko ^c   Berd, David ^a   Mastrangelo, Michael J ^a   Sato, Takami ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cytokine receptors; Cytokines; Immunoadhesin; Interleukin 10; Melanoma

Indexed keywords

CHIMERIC ANTIBODY; HUMAN INTERLEUKIN 10 RECEPTOR 1 IMMUNOGLOBULIN G1 FC FUSION PROTEIN; HYBRID PROTEIN; IMMUNOADHESIN; INTERLEUKIN 10 ANTIBODY; MONOCLONAL ANTIBODY; PLASMID VECTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

CELL LINE, TUMOR; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR ALPHA SUBUNIT; MELANOMA; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 67349098558     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0644-9     Document Type: Article

References (42)

1. K Asadullah W Sterry HD Volk 2003 Interleukin-10 therapy-review of a new approach Pharmacol Rev 55 241 269
2. MV Barrera S Habicheyn MV Mendiola E Herrera Ceballos 2008 Etanercept in the treatment and retreatment of psoriasis in daily clinical practice Eur J Dermatol 18 683 687
3. S Beckebaum X Zhang X Chen Z Yu A Frilling G Dworacki H Grosse-Wilde CE Broelsch G Gerken VR Cicinnati 2004 Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets Clin Cancer Res 10 7260 7269 (Pubitemid 39487713)
4. JY Blay N Burdin F Rousset G Lenoir P Biron T Philip J Banchereau MC Favrot 1993 Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor Blood 82 2169 2174 (Pubitemid 23294002)
5. DG Brooks AM Lee H Elsaesser DB McGavern MB Oldstone 2008 IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection J Exp Med 205 533 541
6. SM Chamow A Ashkenazi 1996 Immunoadhesins: principles and applications Trends Biotechnol 14 52 60 (Pubitemid 26056342)
7. A D'Andrea M Aste-Amezaga MN Valiante X Ma MGT Kubin 1993 Interleukine 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killter cell stimulatory factor/IL-10 synthesis in accessory cells J Exp Med 178 1041 1048 (Pubitemid 23260442)
8. F De Vita M Orditura G Galizia C Romano A Roscigno E Lieto G Catalano 2000 Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients Chest 117 365 373 (Pubitemid 30111584)
9. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE (1992) Interleukin-10. Curr Opin Immunol 4:314-320
10. Y Denizot P Turlure D Bordessoule F Trimoreau V Praloran 1999 Serum IL-10 and IL-13 concentrations in patients with haematological malignancies Cytokine 11 634 635 (Pubitemid 29368983)
11. JH Donohue SA Rosenberg 1983 The fate of interleukin-2 after in vivo administration J Immunol 130 2203 2208
12. DF Fiorentino MW Bond TR Mosmann 1989 Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 2081 2095
13. NR Gascoigne CC Goodnow KI Dudzik VT Oi MM Davis 1987 Secretion of a chimeric T-cell receptor-immunoglobulin protein Proc Natl Acad Sci USA 84 2936 2940 (Pubitemid 17064753)
14. M Howard A O'Garra 1992 Biological properties of interleukin 10 Immunol Today 13 198 200
15. BC Jones NJ Logsdon K Josephson J Cook PA Barry MR Walter 2002 Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1 Proc Natl Acad Sci USA 99 9404 9409 (Pubitemid 34764626)
16. K Josephson NJ Logsdon MR Walter 2001 Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site Immunity 15 35 46 (Pubitemid 32728318)
17. J Kim RL Modlin RL Moy SM Dubinett T McHugh BJ Nickoloff K Uyemura 1995 IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response J Immunol 155 2240 2247
18. T Kohno LT Tam SR Stevens JS Louie 2007 Binding characteristics of tumor necrosis factor receptor (TNFR)-Fc fusion proteins vs anti-tumor necrosis factor mAbs J Investig Dermatol Symp Proc 12 5 8 (Pubitemid 46763031)
19. SV Kotenko CD Krause LS Izotova BP Pollack W Wu S Pestka 1997 Identification and functional characterization of a second chain of the interleukin-10 receptor complex EMBO J 16 5894 5903 (Pubitemid 27427285)
20. SV Kotenko S Pestka 2000 Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes Oncogene 19 2557 2565 (Pubitemid 30339211)
21. SN Liossis GC Tsokos 2005 Monoclonal antibodies and fusion proteins in medicine J Allergy Clin Immunol 116 721 729 quiz 30 (Pubitemid 41400530)
22. Y Liu SH Wei AS Ho R l Malefyt KW Moore 1994 Expression cloning and characterization of a human IL-10 receptor J Immunol 152 1821 1829
23. G Lutfalla K Gardiner G Uze 1993 A new member of the cytokine receptor gene family maps on chromosome 21 at less than 35 kb from IFNAR Genomics 16 366 373 (Pubitemid 23170891)
24. M Matsuda F Salazar M Petersson G Masucci J Hansson P Pisa QJ Zhang G Masucci R Kiessling 1994 Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression J Exp Med 180 2371 2376
25. JM McBride T Jung JE de Vries G Aversa 2002 IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses Cell Immunol 215 162 172
26. S Mocellin M Panelli E Wang CR Rossi P Pilati D Nitti M Lise FM Marincola 2004 IL-10 stimulatory effects on human NK cells explored by gene profile analysis Genes Immun 5 621 630 (Pubitemid 40045300)
27. KW Moore A O'Garra R l Malefyt P Vieira TR Mosmann 1993 Interleukin-10 Annu Rev Immunol 11 165 190 (Pubitemid 23115005)
28. RW Nadeau H Satoh S Scheide R Crowl R Conroy WA Garland DJ Liberato 1995 A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys Drug Metab Dispos 23 904 909
29. L Novak O Igoucheva S Cho V Alexeev 2007 Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication Mol Cancer Ther 6 1755 1764 (Pubitemid 46954052)
30. J Ordemann CA Jacobi C Braumann W Schwenk HD Volk JM Muller 2002 Immunomodulatory changes in patients with colorectal cancer Int J Colorectal Dis 17 37 41 (Pubitemid 41398989)
31. KB Patel D Berd MJ Mastrangelo M Terai T Sato 2002 Prognostic importance of interleukin-10 (IL-10) production by metastatic melanoma tissues from patients receiving autologous vaccine therapy Proc of ASCO 21 432a
32. JM Reuben BN Lee C Li J Gomez-Navarro VA Bozon CA Parker IM Hernandez C Gutierrez G Lopez-Berestein LH Camacho 2006 Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma Cancer 106 2437 2444 (Pubitemid 43787668)
33. JS Rudge G Thurston S Davis N Papadopoulos N Gale SJ Wiegand GD Yancopoulos 2005 VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene-based discovery of the next generation of angiogenesis targets Cold Spring Harb Symp Quant Biol 70 411 418 (Pubitemid 44124896)
34. F Salazar-Onfray J Charo M Petersson S Freland G Noffz Z Qin T Blankenstein HG Ljunggren R Kiessling 1997 Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 J Immunol 159 3195 3202 (Pubitemid 127482077)
35. T Sato P McCue K Masuoka S Salwen EC Lattime MJ Mastrangelo D Berd 1996 Interleukin 10 production by human melanoma Clin Cancer Res 2 1383 1390 (Pubitemid 26299438)
36. SD Spencer F Di Marco J Hooley S Pitts-Meek M Bauer AM Ryan B Sordat VC Gibbs M Aguet 1998 The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor J Exp Med 187 571 578 (Pubitemid 28093359)
37. ME Stearns FU Garcia K Fudge J Rhim M Wang 1999 Role of interleukin 10 and transforming growth factor beta 1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice Clin Cancer Res 5 711 720 (Pubitemid 29131984)
38. ME Stearns J Rhim M Wang 1999 Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion Clin Cancer Res 5 189 196 (Pubitemid 29045193)
39. K Steinbrink E Graulich S Kubsch J Knop A Enk 2002 CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity Blood 99 2468 2476 (Pubitemid 34525434)
40. JL Touraine K Sanhadji R Sembeil 2003 Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model Isr Med Assoc J 5 863 867 (Pubitemid 38008107)
41. N Uwatoko T Tokunaga H Hatanaka H Osada T Kawakami H Yamazaki Y Abe H Kijima Y Ueyama M Nakamura 2002 Expression of IL-10 is inversely correlated with distant metastasis of renal cell carcinoma Int J Oncol 20 729 733
42. FY Yue R Dummer R Geertsen G Hofbauer E Laine S Manolio G Burg 1997 Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules Int J Cancer 71 630 637 (Pubitemid 27239375)